Advising Invivo Partners on the launch of its new fund, Invivo Ventures III
Invivo Partners, a fund manager co-founded by Dr. Luis Pareras and Albert Ferrer, has launched its new Invivo Ventures III fund, with a target size of €100 million and which will focus its investment on life sciences companies at the forefront of innovation, especially those involved in advanced therapies and synthetic biology.
With a majority of private investors and the backing of prominent institutional investors, Invivo Ventures III is primed to make a substantial impact on the life sciences ecosystem.
The team led by Josu Ibarzabal and Mercedes Fraile, Director and Manager of the Innovation and Entrepreneurship Area, respectively, advised the venture capital management company on this transaction.